Emilia Riggi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emilia Riggi has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
Nereo Segnan
S.S.D. Epidemiologia Screening – CPO. AOU Città della Salute e della Scienza di Torino, Turin, Italy
6 shared publications- Cecilia Stålsby Lundborg
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
4 shared publications - Ashok J. Tamhankar
Global Health-Health Systems and Policy: Medicines, Focusing Antibiotics, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
3 shared publications Carlo Senore
S.S.D. Epidemiologia Screening – CPO. AOU Città della Salute e della Scienza di Torino, Turin, Italy
3 shared publications- Carlo Senore
Epidemiology and screening unit - CPO, University Hospital Città della Salute e della Scienza, Turin, Italy
3 shared publications Gaetano Marrone
Global Health – Health Systems and Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
3 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 15 (4) , e250180
Target trial emulation: bridging observational studies and randomized trials for health decision-making
Randomized controlled trials (RCTs) are the gold standard generating evidence owing to their rigorous methodology. However, their logistical, financial and ethical limitations highlight the need for alternative approaches using real-world data. Target trial emulation (TTE) applies RCT design principles to estimate causal effects when trials are infeasible. TTE involves three steps: formulating a precise causal research question, explicitly specifying the protocol of the target trial, and rigorously replicating each component of the target trial, such as the eligibility criteria, treatment assignment and follow-up period, using available observational data. Statistical methods commonly used include propensity score matching, inverse probability weighting, G-methods and/or instrumental variables to address confounding and align observational data with the target trial design. Nonetheless, residual confounding, missing data and misclassification can bias results. Sensitivity analyses and transparent reporting are recommended. Notably, TTE frameworks utilizing continuously updated registry data enable ‘living protocols’ that can be iteratively refined as new data accumulate, representing an important evolution toward prospective-retrospective hybrid designs that maintain causal clarity while addressing emerging clinical questions. Though valuable, TTE complements rather than replaces RCTs, as both inform causal inference and clinical decisions.
- 1 April 2026
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 15 (4) , e250180
Open AccessTarget trial emulation: bridging observational studies and randomized trials for health decision-making
Randomized controlled trials (RCTs) are the gold standard generating evidence owing to their rigorous methodology. However, their logistical, financial and ethical limitations highlight the need for alternative approaches using real-world data. Target trial emulation (TTE) applies RCT design principles to estimate causal effects when trials are infeasible. TTE involves three steps: formulating a precise causal research question, explicitly specifying the protocol of the target trial, and rigorously replicating each component of the target trial, such as the eligibility criteria, treatment assignment and follow-up period, using available observational data. Statistical methods commonly used include propensity score matching, inverse probability weighting, G-methods and/or instrumental variables to address confounding and align observational data with the target trial design. Nonetheless, residual confounding, missing data and misclassification can bias results. Sensitivity analyses and transparent reporting are recommended. Notably, TTE frameworks utilizing continuously updated registry data enable ‘living protocols’ that can be iteratively refined as new data accumulate, representing an important evolution toward prospective-retrospective hybrid designs that maintain causal clarity while addressing emerging clinical questions. Though valuable, TTE complements rather than replaces RCTs, as both inform causal inference and clinical decisions.
- Open Access
- 15 May 2025
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 25 (1) , 1-11
Warnings on the inclusion of cluster randomized trials in meta-analysis: results of a simulation study
Consolidation of treatment effects from randomized controlled trials (RCT) is considered one of the highest forms of evidence in research. Cluster randomized trials (CRT) are increasingly used in the assessment of the effectiveness of interventions when individual-level randomization is impractical. In meta-analyses, CRTs that address the same clinical question as RCTs can be pooled in the same analysis; however, they need to be analyzed with appropriate statistical methods. This study examined the extent to which meta-analysis results are influenced by the inclusion of incorrectly analyzed CRTs through a series of simulations. RCT and CRT datasets were generated with a continuous treatment effect of zero, two trial arms, and equal number of participants. CRT datasets were generated with varying number of clusters (10, 20 or 40), observations per cluster (10, 30 or 50), total variance (1, 5 or 10) and ICC (0.05, 0.10 or 0.20). Each simulated CRT dataset (n = 1000 for each scenario) was analyzed using standard linear regression and mixed-effects regression with clusters treated as random effects to represent the incorrectly and correctly analyzed CRTs. Meta-analytic datasets were created by varying the total number of studies (4, 8 or 12), number of CRTs out of the total number of studies (single, half or all), and the number of correctly analyzed CRTs (none, half or all). Model performance was summarized from 1000 random-effects meta-analyses for each scenario. The percentage of statistically significant results (at p < 0.05) was consistently lower when all CRTs were correctly analyzed. The alpha threshold (5%) was exceeded in 6 (2.47%) of 243 scenarios when all CRTs were correctly analyzed, compared to 177 (72.84%) and 195 (80.25%) scenarios when half or none of the CRTs were correctly analyzed, respectively. Coverage probabilities and model-based SEs were higher when all CRTs were correctly analyzed, while the estimated effect sizes and bias averaged across iterations showed no differences regardless of the number of correctly analyzed CRTs. Ignoring clustering in CRTs lead to inflated false-positive conclusions about the efficacy of treatments, highlighting the need for caution and proper analytical methods when incorporating CRTs into meta-analyses.
- 15 May 2025
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 25 (1) , 1-11
Open AccessWarnings on the inclusion of cluster randomized trials in meta-analysis: results of a simulation study
Consolidation of treatment effects from randomized controlled trials (RCT) is considered one of the highest forms of evidence in research. Cluster randomized trials (CRT) are increasingly used in the assessment of the effectiveness of interventions when individual-level randomization is impractical. In meta-analyses, CRTs that address the same clinical question as RCTs can be pooled in the same analysis; however, they need to be analyzed with appropriate statistical methods. This study examined the extent to which meta-analysis results are influenced by the inclusion of incorrectly analyzed CRTs through a series of simulations. RCT and CRT datasets were generated with a continuous treatment effect of zero, two trial arms, and equal number of participants. CRT datasets were generated with varying number of clusters (10, 20 or 40), observations per cluster (10, 30 or 50), total variance (1, 5 or 10) and ICC (0.05, 0.10 or 0.20). Each simulated CRT dataset (n = 1000 for each scenario) was analyzed using standard linear regression and mixed-effects regression with clusters treated as random effects to represent the incorrectly and correctly analyzed CRTs. Meta-analytic datasets were created by varying the total number of studies (4, 8 or 12), number of CRTs out of the total number of studies (single, half or all), and the number of correctly analyzed CRTs (none, half or all). Model performance was summarized from 1000 random-effects meta-analyses for each scenario. The percentage of statistically significant results (at p < 0.05) was consistently lower when all CRTs were correctly analyzed. The alpha threshold (5%) was exceeded in 6 (2.47%) of 243 scenarios when all CRTs were correctly analyzed, compared to 177 (72.84%) and 195 (80.25%) scenarios when half or none of the CRTs were correctly analyzed, respectively. Coverage probabilities and model-based SEs were higher when all CRTs were correctly analyzed, while the estimated effect sizes and bias averaged across iterations showed no differences regardless of the number of correctly analyzed CRTs. Ignoring clustering in CRTs lead to inflated false-positive conclusions about the efficacy of treatments, highlighting the need for caution and proper analytical methods when incorporating CRTs into meta-analyses.
- Open Access
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0322416
No acceleration of recovery from exercise-induced muscle damage after cold or hot water immersion in women: A randomised controlled trial
This study compared the effects of cold water immersion (CWI) and hot water immersion (HWI) on muscle recovery following a muscle-damaging exercise protocol in women. Thirty healthy women (23.3 ± 2.9 years) were randomly assigned to either the CWI, HWI, or control (CON) groups. Participants completed a standardised exercise protocol (5 x 20 drop-jumps), followed by a 10 min recovery intervention (CWI, HWI, or CON) immediately and 120 min post-exercise. Physiological responses, including muscle oxygen saturation (SmO2), core and skin temperature, and heart rate, were assessed at baseline, immediately post-exercise, after the first recovery intervention (postInt), and during 30 min follow-up. Recovery was evaluated through maximal voluntary isometric contraction, muscle swelling, muscle soreness ratings, and serum creatine kinase at baseline, 24, 48, and 72 h post-exercise. A mixed-effects model was used to account for repeated measures over time. Results showed lower SmO2 values in the CWI compared to the HWI group at 20 min (Δ-6.76%, CI: −0.27 to −13.25, p = 0.038) and 30 min (Δ-9.86%, CI: −3.37 to −16.35, p = 0.001), and compared to CON at 30 min (Δ-7.28%, CI: −13.77 to −0.79, p = 0.022). Core temperature was significantly higher in the HWI than the CWI group (postInt and 30 min), while it was significantly lower in the CWI group than CON (30 min). CWI caused a substantial decrease in skin temperature compared to HWI and CON between postInt and 30 min follow-up (all p < 0.001). Skin temperature was higher in the HWI group compared to CON at postInt and throughout 30 min follow-up (all p < 0.001). No significant differences in recovery markers were observed between CWI and HWI groups, although HWI led to slightly higher creatine kinase levels (24 h and 72 h) and greater muscle swelling (24 h) compared to CON. Despite distinct acute physiological responses to CWI and HWI, neither improved subjective or objective recovery outcomes during the 72 h follow-up compared to CON in women following a muscle-damaging exercise protocol. Trial registration number: NCT04902924 (ClinicalTrials.gov), SNCTP000004468 (Swiss National Clinical Trial Portal).
- 7 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0322416
Open AccessNo acceleration of recovery from exercise-induced muscle damage after cold or hot water immersion in women: A randomised controlled trial
This study compared the effects of cold water immersion (CWI) and hot water immersion (HWI) on muscle recovery following a muscle-damaging exercise protocol in women. Thirty healthy women (23.3 ± 2.9 years) were randomly assigned to either the CWI, HWI, or control (CON) groups. Participants completed a standardised exercise protocol (5 x 20 drop-jumps), followed by a 10 min recovery intervention (CWI, HWI, or CON) immediately and 120 min post-exercise. Physiological responses, including muscle oxygen saturation (SmO2), core and skin temperature, and heart rate, were assessed at baseline, immediately post-exercise, after the first recovery intervention (postInt), and during 30 min follow-up. Recovery was evaluated through maximal voluntary isometric contraction, muscle swelling, muscle soreness ratings, and serum creatine kinase at baseline, 24, 48, and 72 h post-exercise. A mixed-effects model was used to account for repeated measures over time. Results showed lower SmO2 values in the CWI compared to the HWI group at 20 min (Δ-6.76%, CI: −0.27 to −13.25, p = 0.038) and 30 min (Δ-9.86%, CI: −3.37 to −16.35, p = 0.001), and compared to CON at 30 min (Δ-7.28%, CI: −13.77 to −0.79, p = 0.022). Core temperature was significantly higher in the HWI than the CWI group (postInt and 30 min), while it was significantly lower in the CWI group than CON (30 min). CWI caused a substantial decrease in skin temperature compared to HWI and CON between postInt and 30 min follow-up (all p < 0.001). Skin temperature was higher in the HWI group compared to CON at postInt and throughout 30 min follow-up (all p < 0.001). No significant differences in recovery markers were observed between CWI and HWI groups, although HWI led to slightly higher creatine kinase levels (24 h and 72 h) and greater muscle swelling (24 h) compared to CON. Despite distinct acute physiological responses to CWI and HWI, neither improved subjective or objective recovery outcomes during the 72 h follow-up compared to CON in women following a muscle-damaging exercise protocol. Trial registration number: NCT04902924 (ClinicalTrials.gov), SNCTP000004468 (Swiss National Clinical Trial Portal).
- 8 February 2024
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 22 (3) , 447-452
Bayesian approach for meta-analyses in biomedical research: a scoping review protocol
Objective: The overarching aim of this scoping review is to describe and analyze the scope of use and reporting of Bayesian methods in meta-analyses in biomedical research. Introduction: The Bayesian approach provides a powerful and flexible framework for meta-analysis, particularly suited for dealing with complex, sparse, or heterogeneous data. Due to these advantages and its appeal, Bayesian methods have been increasingly used in many areas of biomedical research; however, their use in meta-analysis remains scarce. Inclusion criteria: This review will include studies that used Bayesian methods for meta-analysis of primary studies in biomedical research. Methods: The proposed review will be conducted in accordance with the JBI methodology for scoping reviews. PubMed, Embase, CINAHL, and the Cochrane Database of Systematic Reviews will be searched to identify relevant full-text papers published since 2016 in English. No geographical restriction will be applied. Two reviewers will screen the articles and extract the data using a tool that will be pilot-tested and revised, as necessary. Analysis will involve frequency counts, narrative synthesis, and mapping concepts to propose an appropriate workflow. The details of the scoping review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guideline. Review registration: Open Science Framework https://osf.io/jenp4/
- 8 February 2024
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 22 (3) , 447-452
Bayesian approach for meta-analyses in biomedical research: a scoping review protocol
Objective: The overarching aim of this scoping review is to describe and analyze the scope of use and reporting of Bayesian methods in meta-analyses in biomedical research. Introduction: The Bayesian approach provides a powerful and flexible framework for meta-analysis, particularly suited for dealing with complex, sparse, or heterogeneous data. Due to these advantages and its appeal, Bayesian methods have been increasingly used in many areas of biomedical research; however, their use in meta-analysis remains scarce. Inclusion criteria: This review will include studies that used Bayesian methods for meta-analysis of primary studies in biomedical research. Methods: The proposed review will be conducted in accordance with the JBI methodology for scoping reviews. PubMed, Embase, CINAHL, and the Cochrane Database of Systematic Reviews will be searched to identify relevant full-text papers published since 2016 in English. No geographical restriction will be applied. Two reviewers will screen the articles and extract the data using a tool that will be pilot-tested and revised, as necessary. Analysis will involve frequency counts, narrative synthesis, and mapping concepts to propose an appropriate workflow. The details of the scoping review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guideline. Review registration: Open Science Framework https://osf.io/jenp4/
- Open Access
- 12 July 2022
- Published by SAGE Publications in Journal of Public Health Research
- Vol. 11 (3)
Promoting healthy lifestyle habits among participants in cancer screening programs: Results of the randomized controlled Sti.Vi study
Background: Unhealthy diets, physical inactivity, alcohol and tobacco consumption are among the leading risk factors for non-communicable diseases. It is estimated that around 40% of cancers could be prevented by adopting healthy lifestyles. Design and methods: The Stili di Vita (Sti.Vi) study was a randomized study for assessing the impact of healthy lifestyle interventions on anthropometric measures, metabolic parameters, and health outcomes among participants of cancer screening programs in Turin (Italy). Eligible women aged 50–54 years, invited to biennial mammography screening, and 58-years-old men and women, invited to a once-only sigmoidoscopy for colorectal cancer (CRC) screening were randomly allocated to Diet group (DG), Physical Activity group (PAG), Physical Activity plus Diet group (PADG), or control group (CG). Physical and eating habits, metabolic and anthropometric measurements, repeatedly collected, were the study outcomes. The active intervention, offered to participants assigned to the DG, PAG, and PADG arms, consisted of a basic module and an advanced module. The effect of the interventions was estimated through logistic regression or a difference in differences approach. A multiple imputation procedure was implemented to deal with missing values and q-values have been calculated in the presence of multiple hypothesis testing. Results: Out of the 8442 screened attendees, 1270 signed informed consent, while 1125 participants accomplished the baseline visit. Participants were equally distributed across the four treatments as following: 273 (24.3%) in DG, 288 (25.6%) in the PAG, 283 (25.1%) in PADG, and 281 (25%) in the CG. Participants assigned to DG or PADG increased their consumption of whole grains (OR = 1.77, 95% CI: 1.20–2.60 and OR = 1.55, 95% CI: 1.06–2.27, respectively) and legumes (OR = 1.77, 95% CI: 1.12–2.79 and OR = 2.24, 95% CI: 1.41–3.57, respectively), with respect to CG. The participants randomized to DG reduced processed meat and increased fruit consumption (OR = 2.57, 95% CI: 1.76–3.76 and OR = 2.38, 95% CI: 1.12–5.06, respectively). The effects were more evident in the CRC screening subgroup. No relevant difference was observed between PAG and CG. No impact was observed on physical activity habits. Conclusions: Our findings suggest that active interventions can increase awareness and induce diet changes. However, participation rate and compliance to the courses was quite low, innovative strategies to enhance participants’ retention are needed, with the ultimate goal of increasing awareness and inducing positive lifestyle changes.
- 12 July 2022
- Published by SAGE Publications in Journal of Public Health Research
- Vol. 11 (3)
Open AccessPromoting healthy lifestyle habits among participants in cancer screening programs: Results of the randomized controlled Sti.Vi study
Background: Unhealthy diets, physical inactivity, alcohol and tobacco consumption are among the leading risk factors for non-communicable diseases. It is estimated that around 40% of cancers could be prevented by adopting healthy lifestyles. Design and methods: The Stili di Vita (Sti.Vi) study was a randomized study for assessing the impact of healthy lifestyle interventions on anthropometric measures, metabolic parameters, and health outcomes among participants of cancer screening programs in Turin (Italy). Eligible women aged 50–54 years, invited to biennial mammography screening, and 58-years-old men and women, invited to a once-only sigmoidoscopy for colorectal cancer (CRC) screening were randomly allocated to Diet group (DG), Physical Activity group (PAG), Physical Activity plus Diet group (PADG), or control group (CG). Physical and eating habits, metabolic and anthropometric measurements, repeatedly collected, were the study outcomes. The active intervention, offered to participants assigned to the DG, PAG, and PADG arms, consisted of a basic module and an advanced module. The effect of the interventions was estimated through logistic regression or a difference in differences approach. A multiple imputation procedure was implemented to deal with missing values and q-values have been calculated in the presence of multiple hypothesis testing. Results: Out of the 8442 screened attendees, 1270 signed informed consent, while 1125 participants accomplished the baseline visit. Participants were equally distributed across the four treatments as following: 273 (24.3%) in DG, 288 (25.6%) in the PAG, 283 (25.1%) in PADG, and 281 (25%) in the CG. Participants assigned to DG or PADG increased their consumption of whole grains (OR = 1.77, 95% CI: 1.20–2.60 and OR = 1.55, 95% CI: 1.06–2.27, respectively) and legumes (OR = 1.77, 95% CI: 1.12–2.79 and OR = 2.24, 95% CI: 1.41–3.57, respectively), with respect to CG. The participants randomized to DG reduced processed meat and increased fruit consumption (OR = 2.57, 95% CI: 1.76–3.76 and OR = 2.38, 95% CI: 1.12–5.06, respectively). The effects were more evident in the CRC screening subgroup. No relevant difference was observed between PAG and CG. No impact was observed on physical activity habits. Conclusions: Our findings suggest that active interventions can increase awareness and induce diet changes. However, participation rate and compliance to the courses was quite low, innovative strategies to enhance participants’ retention are needed, with the ultimate goal of increasing awareness and inducing positive lifestyle changes.
- 1 January 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (1) , 36-45
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial
Randomized trials from the United Kingdom, Norway, and the United States found a protective effect of screening flexible sigmoidoscopy against colorectal cancer incidence and mortality over 15 to 1... Visual Long-Term Effectiveness of Flexible Sigmoidoscopy Screening. Randomized trials from the United Kingdom, Norway, and the United States found a protective effect of screening flexible... Background: Recent reports showed that the protective effect of flexible sigmoidoscopy (FS) screening was maintained up to17 years, although differences were reported by sex. Objective: To assess l...
- 1 January 2022
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 175 (1) , 36-45
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial
Randomized trials from the United Kingdom, Norway, and the United States found a protective effect of screening flexible sigmoidoscopy against colorectal cancer incidence and mortality over 15 to 1... Visual Long-Term Effectiveness of Flexible Sigmoidoscopy Screening. Randomized trials from the United Kingdom, Norway, and the United States found a protective effect of screening flexible... Background: Recent reports showed that the protective effect of flexible sigmoidoscopy (FS) screening was maintained up to17 years, although differences were reported by sex. Objective: To assess l...
- Open Access
- 22 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 7706
Monitoring of Water Quality, Antibiotic Residues, and Antibiotic-Resistant Escherichia coli in the Kshipra River in India over a 3-Year Period
The emergence of antibiotic resistance is a major global and environmental health issue, yet the presence of antibiotic residues and resistance in the water and sediment of a river subjected to excessive anthropogenic activities and their relationship with water quality of the river are not well studied. The objectives of the present study were a) to investigate the occurrence of antibiotic residues and antibiotic-resistant Escherichia coli (E. coli) in the water and sediment of the Kshipra river in India at seven selected sites during different seasons of the years 2014, 2015, and 2016 and b) to investigate the association between antibiotic residues and antibiotic-resistant E. coli in water and sediment and measured water quality parameters of the river. Antibiotic residues and resistant E. coli were present in the water and sediment and were associated with the measured water quality parameters. Sulfamethoxazole was the most frequently detected antibiotic in water at the highest concentration of 4.66 µg/L and was positively correlated with the water quality parameters. Significant (p < 0.05) seasonal and spatial variations of antibiotic-resistant E. coli in water and sediment were found. The resistance of E. coli to antibiotics (e.g., sulfamethiazole, norfloxacin, ciprofloxacine, cefotaxime, co-trimoxazole, ceftazidime, meropenem, ampicillin, amikacin, metronidazole, tetracycline, and tigecycline) had varying associations with the measured water and sediment quality parameters. Based on the results of this study, it is suggested that regular monitoring and surveillance of water quality, including antibiotic residues and antibiotic resistance, of all rivers should be taken up as a key priority, in national and Global Action Plans as these can have implications for the buildup of antibiotic resistance.
- 22 October 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (21) , 7706
Open AccessMonitoring of Water Quality, Antibiotic Residues, and Antibiotic-Resistant Escherichia coli in the Kshipra River in India over a 3-Year Period
The emergence of antibiotic resistance is a major global and environmental health issue, yet the presence of antibiotic residues and resistance in the water and sediment of a river subjected to excessive anthropogenic activities and their relationship with water quality of the river are not well studied. The objectives of the present study were a) to investigate the occurrence of antibiotic residues and antibiotic-resistant Escherichia coli (E. coli) in the water and sediment of the Kshipra river in India at seven selected sites during different seasons of the years 2014, 2015, and 2016 and b) to investigate the association between antibiotic residues and antibiotic-resistant E. coli in water and sediment and measured water quality parameters of the river. Antibiotic residues and resistant E. coli were present in the water and sediment and were associated with the measured water quality parameters. Sulfamethoxazole was the most frequently detected antibiotic in water at the highest concentration of 4.66 µg/L and was positively correlated with the water quality parameters. Significant (p < 0.05) seasonal and spatial variations of antibiotic-resistant E. coli in water and sediment were found. The resistance of E. coli to antibiotics (e.g., sulfamethiazole, norfloxacin, ciprofloxacine, cefotaxime, co-trimoxazole, ceftazidime, meropenem, ampicillin, amikacin, metronidazole, tetracycline, and tigecycline) had varying associations with the measured water and sediment quality parameters. Based on the results of this study, it is suggested that regular monitoring and surveillance of water quality, including antibiotic residues and antibiotic resistance, of all rivers should be taken up as a key priority, in national and Global Action Plans as these can have implications for the buildup of antibiotic resistance.
- 11 March 2020
- Published by Wiley in International Journal of Cancer
- Vol. 147 (7) , 1855-1863
Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates
Comparable performance indicators for breast cancer screening in the European Union (EU) have not been previously reported. We estimated adjusted breast cancer screening positivity rate (PR) and detection rates (DR) to investigate variation across EU countries. For the age 50–69 years, the adjusted EU‐pooled PR for initial screening was 8.9% (cross‐programme variation range 3.2–19.5%) while DR of invasive cancers was 5.3/1,000 (range 3.8–7.4/1,000) and DR of ductal carcinoma in situ (DCIS) was 1.3/1,000 (range 0.7–2.7/1,000). For subsequent screening, the adjusted EU‐pooled PR was 3.6% (range 1.4–8.4%), the DR was 4.0/1,000 (range 2.2–5.8/1,000) and 0.8/1,000 (range 0.5–1.3/1,000) for invasive and DCIS, respectively. Adjusted performance indicators showed remarkable heterogeneity, likely due to different background breast cancer risk and awareness between target populations, and also different screening protocols and organisation. Periodic reporting of the screening indicators permits comparison and evaluation of the screening activities between and within countries aiming to improve the quality and the outcomes of screening programmes. Cancer Screening Registries would be a milestone in this direction and EU Screening Reports provide a fundamental contribution to building them.
- 11 March 2020
- Published by Wiley in International Journal of Cancer
- Vol. 147 (7) , 1855-1863
Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates
Comparable performance indicators for breast cancer screening in the European Union (EU) have not been previously reported. We estimated adjusted breast cancer screening positivity rate (PR) and detection rates (DR) to investigate variation across EU countries. For the age 50–69 years, the adjusted EU‐pooled PR for initial screening was 8.9% (cross‐programme variation range 3.2–19.5%) while DR of invasive cancers was 5.3/1,000 (range 3.8–7.4/1,000) and DR of ductal carcinoma in situ (DCIS) was 1.3/1,000 (range 0.7–2.7/1,000). For subsequent screening, the adjusted EU‐pooled PR was 3.6% (range 1.4–8.4%), the DR was 4.0/1,000 (range 2.2–5.8/1,000) and 0.8/1,000 (range 0.5–1.3/1,000) for invasive and DCIS, respectively. Adjusted performance indicators showed remarkable heterogeneity, likely due to different background breast cancer risk and awareness between target populations, and also different screening protocols and organisation. Periodic reporting of the screening indicators permits comparison and evaluation of the screening activities between and within countries aiming to improve the quality and the outcomes of screening programmes. Cancer Screening Registries would be a milestone in this direction and EU Screening Reports provide a fundamental contribution to building them.
- 1 February 2020
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 91 (2) , 406-414.e1
Accuracy of colon capsule endoscopy for advanced neoplasia
- 1 February 2020
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 91 (2) , 406-414.e1
Accuracy of colon capsule endoscopy for advanced neoplasia
- 31 December 2019
- Published by Wiley in Head & Neck
- Vol. 42 (5) , 963-973
The role of a post therapeutic surveillance program for sinonasal malignancies: Analysis of 417 patients
Background: Post therapeutic surveillance of head and neck neoplasms is a still debated issue in the current literature: although different works tried to establish frequency, modality, and efficacy of a routine follow‐up, little evidence has been produced, in particular considering only sinonasal malignancies.Methods: A retrospective review of patients treated for sinonasal malignancies in a single tertiary center and followed through a regular program of follow‐up was carried out. Rate of recurrence, location, timing, diagnosis, and salvage treatment were the main data analyzed.Results: Of note, 417 patients were included in the study and 117 experienced at least one relapse. Staging, histological type, and previous treatment represent the main clinical factors to be considered to stratify patient's risk of recurrence.Conclusion: A regular post therapeutic surveillance can provide an early recurrence detection for patients treated for sinonasal malignancies, offering opportunity for salvage treatment in a high percentage of patients.
- 31 December 2019
- Published by Wiley in Head & Neck
- Vol. 42 (5) , 963-973
The role of a post therapeutic surveillance program for sinonasal malignancies: Analysis of 417 patients
Background: Post therapeutic surveillance of head and neck neoplasms is a still debated issue in the current literature: although different works tried to establish frequency, modality, and efficacy of a routine follow‐up, little evidence has been produced, in particular considering only sinonasal malignancies.Methods: A retrospective review of patients treated for sinonasal malignancies in a single tertiary center and followed through a regular program of follow‐up was carried out. Rate of recurrence, location, timing, diagnosis, and salvage treatment were the main data analyzed.Results: Of note, 417 patients were included in the study and 117 experienced at least one relapse. Staging, histological type, and previous treatment represent the main clinical factors to be considered to stratify patient's risk of recurrence.Conclusion: A regular post therapeutic surveillance can provide an early recurrence detection for patients treated for sinonasal malignancies, offering opportunity for salvage treatment in a high percentage of patients.